Homozygous C677T Methylenetetrahydrofolate Reductase (MTHFR) Polymorphism as a Risk Factor for Endometriosis: A Retrospective Case–Control Study
-
Published:2023-10-20
Issue:20
Volume:24
Page:15404
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Delli Carpini Giovanni1, Giannella Luca1ORCID, Di Giuseppe Jacopo1, Montik Nina1, Montanari Michele1, Fichera Mariasole1, Crescenzi Daniele1, Marzocchini Carolina1, Meccariello Maria Liberata1, Di Biase Donato1, Vignini Arianna2ORCID, Ciavattini Andrea1
Affiliation:
1. Gynecologic Section, Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica delle Marche, 60213 Ancona, Italy 2. Section of Biochemistry, Biology and Physics, Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica delle Marche, 60126 Ancona, Italy
Abstract
This study was conducted to evaluate the role of methylenetetrahydrofolate reductase (MTHFR) C677T homozygous polymorphism as a risk factor for endometriosis. A retrospective case–control study was conducted from January 2020 to December 2022 on all patients attending the gynecological outpatient clinic of our institution who had performed an MTHFR polymorphisms test. Patients with endometriosis were considered cases, while those without endometriosis were considered controls. The presence of an MTHFR C677T homozygous polymorphism was defined as exposure. Risk factors for endometriosis were considered confounders in a binomial logistic regression, with endometriosis diagnosis as the dependent variable. Among the 409 included patients, 106 (25.9%) cases and 303 (74.1%) controls were identified. A higher rate of MTHFR C677T homozygous polymorphism was found in patients with endometriosis (24.5% vs. 15.8%, p = 0.0453), with an adOR of 1.889 (95% CI 1.076–3.318, p = 0.0269) at the binomial logistic regression. A history of no previous pregnancy was associated with an endometriosis diagnosis (adOR 2.191, 95% CI 1.295–3.708, p = 0.0035). An MTHFR C677T homozygous polymorphism could be considered a risk factor for endometriosis. Epigenetic modifications may be the most important mechanism explaining the observed association through the processes of altered DNA methylation and reduced activity of antioxidant systems.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference45 articles.
1. Endometriosis: Epidemiology and aetiological factors;Parazzini;Best. Pract. Res. Clin. Obstet. Gynaecol.,2004 2. Pais, A.S., and Almeida-Santos, T. (2023). Recent insights explaining susceptibility to endometriosis-From genetics to environment. WIREs Mech. Dis., e1624. 3. Imperiale, L., Nisolle, M., Noël, J.C., and Fastrez, M. (2023). Three Types of Endometriosis: Pathogenesis, Diagnosis and Treatment. State of the Art. J. Clin. Med., 12. 4. Pathophysiology, diagnosis, and management of endometriosis;Horne;BMJ,2022 5. Ovarian endometriosis and vitamin D serum levels;Ciavattini;Gynecol. Endocrinol.,2017
|
|